Insulet Corporation (PODD)
NASDAQ: PODD · Real-Time Price · USD
313.08
+3.25 (1.05%)
Jun 27, 2025, 4:00 PM - Market closed
Insulet Employees
Insulet had 3,900 employees as of December 31, 2024. The number of employees increased by 900 or 30.00% compared to the previous year.
Employees
3,900
Change (1Y)
900
Growth (1Y)
30.00%
Revenue / Employee
$563,821
Profits / Employee
$103,128
Market Cap
22.03B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
PODD News
- 9 days ago - Insulet to Share Additional Evidence Demonstrating the Impact of Omnipod® 5 on Improved Health Outcomes at the American Diabetes Association 85th Scientific Sessions - Business Wire
- 18 days ago - 20 stocks bucking bad trends on Wall Street — what might be next for them? - Market Watch
- 18 days ago - Insulet's Omnipod® 5 App for iPhone with Dexcom G7 Integration Now Available to all U.S. Users - Business Wire
- 19 days ago - 20 stocks of companies that have improved profit margins and are expected to grow quickly - Market Watch
- 5 weeks ago - Insulet to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025 - Business Wire
- 6 weeks ago - Outlier Money Flows Lift Insulet - FXEmpire
- 6 weeks ago - Insulet Announces Publication of 2024 Sustainability Report - Business Wire
- 6 weeks ago - 20 stocks of companies showing excellent earnings-season trends even as the economy cools - Market Watch